መነሻ › አልዛይመር በሽታ › ካሊፎርኒያ
በካሊፎርኒያ ለአልዛይመር በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአልዛይመር በሽታ የሚደረጉ 48 ጥናቶች በካሊፎርኒያ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በካሊፎርኒያ ውስጥ ያሉ ከተሞች
- Los Angeles14 ጥናቶች
- San Diego12 ጥናቶች
- Irvine11 ጥናቶች
- Long Beach8 ጥናቶች
- Anaheim7 ጥናቶች
- Orange7 ጥናቶች
- San Francisco7 ጥናቶች
- Mountain View6 ጥናቶች
- Concord5 ጥናቶች
- Oakland4 ጥናቶች
- Santa Ana4 ጥናቶች
- Chino3 ጥናቶች
- Riverside3 ጥናቶች
- Murrieta3 ጥናቶች
Official study text (English)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Anaheim
- Clinical Site, Long Beach
- Clinical Site, Murrieta
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Advanced Research Center, Inc, Anaheim
- Sunwise Clinical Research, Walnut Creek
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1657, Anaheim
- Local Institution - 1668, Fresno
- Local Institution - 2625, Long Beach
- እና 6 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Progeny Psychiatric Clinic - Irvine, Irvine
- ATP Clinical Research, Inc - Orange, Orange
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07633470A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- CenExel ACT (Formerly Anaheim Clinical Trials; LLC), Anaheim
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07780383A Study of LY3439539 in Participants With Alzheimer's Disease
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- Inglewood Clinical, Los Angeles
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07598370A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Oakland Clinical- Site Number : 8400010, Oakland
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Advanced Research Center, Inc., Anaheim
- Inland Psychiatric Medical Group (IPMG)-Chino, Chino
- USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06585787Predicting Pre-dementia
- Foster Carr MD, San Diego
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07516119A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Profound Research LLC, Carlsbad
- Irvine Clinical Research, Irvine
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07589595Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Esperanza Clinical, Murrieta
- Oakland Clinical Research, Oakland
- ATP Clinical Research, Inc., Orange
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Sun Valley Research Center, Inc., Imperial
- Irvine Center for Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- እና 5 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ50 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07177352A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Irvine Center for Clinical Research /ID# 277752, Irvine
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ50 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Fullerton Neurology and Headache Center, Fullerton
- Irvine Clinical Research, Irvine
- Inglewood Clinical, Los Angeles
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ60 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Advanced Research Center (ARC) - Anaheim, Anaheim
- Local Institution - 1668, Fresno
- The Neurology Group, Pomona
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- National Institute of Clinical Research, Garden Grove
- Local Institution - 2607, Long Beach
- Accellacare, Long Beach
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07011745A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Irvine Center for Clinical Research, Irvine
- Syrentis Clinical Research, Santa Ana
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07717411Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Saddleback Medical Center, Orange
ተሳታዮችን በመፈለግ ላይ
እድሜ 70 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05929703Alzheimer's Tau Platform: Master Protocol
- University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ50 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06957418Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
- UCLA TMS Clinical and Research Service, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ55 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06597942Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0017, Anaheim
- Inland Psychiatric Medical Group., Chino
- Kaizen Brain Center, La Jolla
- እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Irvine Clinical Research ( Site 1041), Irvine
- Healthy Brain Clinic ( Site 1005), Long Beach
- Inglewood Clinical ( Site 1062), Los Angeles
- እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT07033494Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
- Stanford Medical Center, Palo Alto
ተሳታዮችን በመፈለግ ላይ
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT07178210A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Healthy Brain Clinic, Long Beach
- Anderson Clinical Research, Redlands
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ60 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT06976216Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan
- The Neurology Center of Southern California, Carlsbad
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT07763392Senicapoc in Alzheimer's Disease
- University of California, Davis Alzheimer's Disease Center, Sacramento
- UC Davis Alzheimer's Disease Center East Bay, Walnut Creek
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ55 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT04804241Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of California, San Diego (UCSD) - Medical Center, La Jolla
- University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT06563895A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of California San Diego Medical Center, La Jolla
- University of Southern Califonria, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 2/3ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT05552157A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of California San Diego Medical Center, La Jolla
- University of Southern Califonria, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 2/3ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT06647498A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Care Access - Huntington Beach, Huntington Beach
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- እና 6 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Inland Psychiatric Medical Group., Chino
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Irvine Center for Clinical Research, Irvine
- University of California San Diego, La Jolla
- University of California at Los Angeles, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ26 ጁን 2026 · NCT07094516Polyphenols and Cognitive Decline
- University of California, Los Angeles, Los Angeles
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ጁን 2026 · NCT06507254A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Collaborative Neuroscience Network - CNS, Los Alamitos
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ45 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT06657768TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
- Shiley Marcos Alzheimer's Disease Center, San Diego
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ሜይ 2026 · NCT06548191[18F]PI-2620 Phase 3 Histopathological Study
- UC Los Angeles, Los Angeles
- Esperanza Clinical, Murrieta
- Sutter Health, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- University of California, Irvine School of Medicine, Co-Enrolling through ABC-DS Only, Orange
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ25 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT04165109Cardiac-Control Affecting Learning Through Mindfulness (CALM)
- University of Southern California, Los Angeles
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ50 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ13 ሜይ 2026 · NCT06410157Biomarker Exploration in Aging, Cognition and Neurodegeneration
- University of California, Irvine, Irvine
ተሳታዮችን በመፈለግ ላይደረጃ 3ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጃንዩ 2026 · NCT03860857Bumetanide in Patients With Alzheimer's Disease
- Stanford University, Stanford
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ14 ጃንዩ 2026 · NCT06052163ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።